← Oncology Approval Tracker

FDA DECISION ·

Vivimusta

bendamustine hydrochloride · Slayback Pharma

FDA approvalNew formulationChronic lymphocytic leukemia and indolent B-cell lymphoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Bendamustine injection for adults with CLL or indolent B-cell NHL that progressed during or within six months after rituximab or a rituximab-containing regimen.

LAMPGEN ANALYSIS

Why it matters

The branded injection approval adds a product-specific bendamustine option in established indications.

What research teams should watch

Use Vivimusta’s own preparation and infusion instructions when adding the presentation to a formulary.

PRIMARY RECORDS

Sources